MedPath
NMPA Approval

Parecoxib Sodium for Injection

国药准字H20193293

September 10, 2024

Drug Information

注射用帕瑞昔布钠

注射剂

40mg(按帕瑞昔布计)

化学药品

September 10, 2024

Company Information

Applicant Company

江苏省徐州市金山桥开发区综合区洞山南侧

Manufacturing Company

江苏省徐州市金山桥开发区综合区洞山南侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用帕瑞昔布钠 - NMPA 批准文号 | MedPath